US Stock MarketDetailed Quotes

LXEO Lexeo Therapeutics

Watchlist
  • 12.605
  • -0.405-3.12%
Trading Jul 16 10:50 ET
415.26MMarket Cap-5979P/E (TTM)

Lexeo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
19.09%-14.87M
-9.05%-59.5M
15.91%-13.98M
-18.32%-13.95M
-13.19M
-18.37M
-23.49%-54.56M
-16.63M
-11.79M
-1,310.04%-44.18M
Net income from continuing operations
-16.21%-21.68M
-12.01%-66.39M
2.68%-14.19M
-17.90%-20.11M
---13.44M
---18.66M
-17.10%-59.28M
---14.58M
---17.06M
-882.42%-50.62M
Depreciation and amortization
6.49%476K
60.96%1.84M
10.11%490K
34.50%460K
--446K
--447K
8,707.69%1.15M
--445K
--342K
--13K
Other non cash items
----
--530K
--258K
----
----
----
----
----
----
----
Change In working capital
814.44%4.01M
-17.25%1.48M
55.36%-1.35M
1.36%4.55M
---1.17M
---561K
-70.35%1.79M
---3.02M
--4.49M
3,923.28%6.04M
-Change in prepaid assets
-138.36%-201K
152.46%990K
184.30%698K
-109.89%-44K
---188K
--524K
-247.51%-1.89M
---828K
--445K
-1,470.64%-543K
-Change in payables and accrued expense
707.25%4.52M
-52.56%1.91M
13.18%-1.73M
20.31%5.09M
---706K
---745K
-39.67%4.03M
---1.99M
--4.23M
3,753.57%6.68M
-Change in other current liabilities
7.35%-315K
-366.78%-1.42M
-59.80%-318K
-170.72%-490K
---271K
---340K
---304K
---199K
---181K
--0
-Change in other working capital
----
----
----
----
----
----
50.54%-46K
--0
--0
-911.87%-93K
Cash from discontinued investing activities
Operating cash flow
19.09%-14.87M
-9.05%-59.5M
15.91%-13.98M
-18.32%-13.95M
---13.19M
---18.37M
-23.49%-54.56M
---16.63M
---11.79M
-1,310.04%-44.18M
Investing cash flow
Cash flow from continuing investing activities
-193K
81.69%-165K
31.78%-73K
86.75%-53K
-39K
0
-379.26%-901K
-107K
-400K
-188K
Net PPE purchase and sale
---185K
82.89%-115K
-192.00%-73K
99.16%-3K
---39K
--0
-257.45%-672K
---25K
---356K
---188K
Net intangibles purchase and sale
---8K
78.17%-50K
--0
-13.64%-50K
--0
--0
---229K
---82K
---44K
--0
Cash from discontinued investing activities
Investing cash flow
---193K
81.69%-165K
31.78%-73K
86.75%-53K
---39K
--0
-379.26%-901K
---107K
---400K
---188K
Financing cash flow
Cash flow from continuing financing activities
90,563.27%88.65M
54,815.87%103.79M
123,644.44%100.07M
11,277.14%3.91M
-94K
-98K
-99.87%189K
-81K
-35K
365.91%150.86M
Net issuance payments of debt
0.91%-109K
2,293.25%3.58M
2.78%-105K
10,913.89%3.89M
---103K
---110K
---163K
---108K
---36K
--0
Net common stock issuance
--88.75M
--100.25M
----
----
----
--0
--0
----
----
----
Net preferred stock issuance
----
--0
--0
--0
----
----
-99.99%20K
---1K
--1K
403.53%151.06M
Proceeds from stock option exercised by employees
-16.67%10K
-84.64%51K
--0
--30K
--9K
--12K
95.29%332K
--28K
--0
--170K
Net other financing activities
----
---86K
---75K
----
----
----
----
----
----
-66.83%-373K
Cash from discontinued financing activities
Financing cash flow
90,563.27%88.65M
54,815.87%103.79M
123,644.44%100.07M
11,277.14%3.91M
---94K
---98K
-99.87%189K
---81K
---35K
365.91%150.86M
Net cash flow
Beginning cash position
54.76%124.72M
-40.68%80.59M
-60.27%38.7M
-58.46%45.54M
--62.12M
--80.59M
362.53%135.86M
--97.4M
--109.63M
22,872.78%29.37M
Current changes in cash
498.41%73.59M
179.84%44.13M
592.23%82.76M
44.06%-6.84M
---13.32M
---18.47M
-151.90%-55.27M
---16.81M
---12.22M
264.12%106.49M
End cash Position
219.26%198.31M
54.76%124.72M
54.76%124.72M
-60.27%38.7M
--45.54M
--62.12M
-40.68%80.59M
--80.59M
--97.4M
362.53%135.86M
Free cash flow
18.04%-15.06M
-7.57%-59.66M
16.01%-14.05M
-14.87%-14M
---13.23M
---18.37M
-25.00%-55.46M
---16.73M
---12.19M
-1,316.04%-44.37M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 19.09%-14.87M-9.05%-59.5M15.91%-13.98M-18.32%-13.95M-13.19M-18.37M-23.49%-54.56M-16.63M-11.79M-1,310.04%-44.18M
Net income from continuing operations -16.21%-21.68M-12.01%-66.39M2.68%-14.19M-17.90%-20.11M---13.44M---18.66M-17.10%-59.28M---14.58M---17.06M-882.42%-50.62M
Depreciation and amortization 6.49%476K60.96%1.84M10.11%490K34.50%460K--446K--447K8,707.69%1.15M--445K--342K--13K
Other non cash items ------530K--258K----------------------------
Change In working capital 814.44%4.01M-17.25%1.48M55.36%-1.35M1.36%4.55M---1.17M---561K-70.35%1.79M---3.02M--4.49M3,923.28%6.04M
-Change in prepaid assets -138.36%-201K152.46%990K184.30%698K-109.89%-44K---188K--524K-247.51%-1.89M---828K--445K-1,470.64%-543K
-Change in payables and accrued expense 707.25%4.52M-52.56%1.91M13.18%-1.73M20.31%5.09M---706K---745K-39.67%4.03M---1.99M--4.23M3,753.57%6.68M
-Change in other current liabilities 7.35%-315K-366.78%-1.42M-59.80%-318K-170.72%-490K---271K---340K---304K---199K---181K--0
-Change in other working capital ------------------------50.54%-46K--0--0-911.87%-93K
Cash from discontinued investing activities
Operating cash flow 19.09%-14.87M-9.05%-59.5M15.91%-13.98M-18.32%-13.95M---13.19M---18.37M-23.49%-54.56M---16.63M---11.79M-1,310.04%-44.18M
Investing cash flow
Cash flow from continuing investing activities -193K81.69%-165K31.78%-73K86.75%-53K-39K0-379.26%-901K-107K-400K-188K
Net PPE purchase and sale ---185K82.89%-115K-192.00%-73K99.16%-3K---39K--0-257.45%-672K---25K---356K---188K
Net intangibles purchase and sale ---8K78.17%-50K--0-13.64%-50K--0--0---229K---82K---44K--0
Cash from discontinued investing activities
Investing cash flow ---193K81.69%-165K31.78%-73K86.75%-53K---39K--0-379.26%-901K---107K---400K---188K
Financing cash flow
Cash flow from continuing financing activities 90,563.27%88.65M54,815.87%103.79M123,644.44%100.07M11,277.14%3.91M-94K-98K-99.87%189K-81K-35K365.91%150.86M
Net issuance payments of debt 0.91%-109K2,293.25%3.58M2.78%-105K10,913.89%3.89M---103K---110K---163K---108K---36K--0
Net common stock issuance --88.75M--100.25M--------------0--0------------
Net preferred stock issuance ------0--0--0---------99.99%20K---1K--1K403.53%151.06M
Proceeds from stock option exercised by employees -16.67%10K-84.64%51K--0--30K--9K--12K95.29%332K--28K--0--170K
Net other financing activities -------86K---75K-------------------------66.83%-373K
Cash from discontinued financing activities
Financing cash flow 90,563.27%88.65M54,815.87%103.79M123,644.44%100.07M11,277.14%3.91M---94K---98K-99.87%189K---81K---35K365.91%150.86M
Net cash flow
Beginning cash position 54.76%124.72M-40.68%80.59M-60.27%38.7M-58.46%45.54M--62.12M--80.59M362.53%135.86M--97.4M--109.63M22,872.78%29.37M
Current changes in cash 498.41%73.59M179.84%44.13M592.23%82.76M44.06%-6.84M---13.32M---18.47M-151.90%-55.27M---16.81M---12.22M264.12%106.49M
End cash Position 219.26%198.31M54.76%124.72M54.76%124.72M-60.27%38.7M--45.54M--62.12M-40.68%80.59M--80.59M--97.4M362.53%135.86M
Free cash flow 18.04%-15.06M-7.57%-59.66M16.01%-14.05M-14.87%-14M---13.23M---18.37M-25.00%-55.46M---16.73M---12.19M-1,316.04%-44.37M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg